Risk Assessment for Breast Cancer: Women Show Surging Interest in Online Calculator Use

women marking off a list with check marks

Risk assessment is critical to help determine whether a woman may be at increased risk for developing breast cancer and to ensure the most appropriate testing is provided. Just ask actress Olivia Munn. Although her mammogram results were normal and BRCA-gene testing was negative, her doctor still recommended the use of a simple breast cancer […]

World Dense Breast Day and How MagView Collects, Displays & Communicates Breast Density

MagView is a proud participant of World Dense Breast Day 2024.

Mark your calendars for the last Wednesday in September to help celebrate a key healthcare event: World Dense Breast Day, which aims to put breast density in the spotlight. What is World Dense Breast Day? Sponsored by DenseBreast-info.org, World Dense Breast Day is a “one-day social media blitz” to “raise awareness about dense breasts and […]

2024 NAPBC Standards: How MagView Supports New Risk Assessment Requirements

National Accreditation Program for Breast Centers (NAPBC) logo

The 2024 NAPBC Standards are now in effect! These new standards from the National Accreditation Program for Breast Centers (NAPBC) focus on the patient care continuum “from screening and prevention, to diagnosis, treatment, and survivorship,” emphasizing the provision of “value-based care with multidisciplinary support.” Effective January 1, 2024, the new standards require breast centers to […]

Radiologists and Risk Assessment: Employing the Tyrer-Cuzick Score in the Reporting Workflow

"Patient's estimated lifetime risk of breast cancer is 23%"

In the U.S., approximately 1 in 8 women can expect to get breast cancer sometime during their lives. Since early detection is such a critical weapon in the fight against breast cancer, risk assessment is essential to help identify women who can benefit from more intensive breast cancer surveillance. Using breast cancer risk assessment models such as Tyrer-Cuzick in […]

MagView Introduces a Stand-Alone Software for High-Risk Breast Cancer Screening

Luminary Risk is MagView's new stand-alone software for breast cancer risk assessment

Fulton, MD – November 20, 2023 – MagView, a leading healthcare solutions provider, introduces Luminary Risk, an advanced software that enhances high-risk breast screening programs. Recognizing the importance of early detection and personalized care, MagView has launched Luminary Risk, as a dedicated software solution that expands the capabilities of high-risk breast screening programs with advanced […]

How Breast Centers Incorporate Tyrer-Cuzick in Mammogram Reports and Lay Letters

automating mammography reports

Using breast cancer risk assessment models—such as Tyrer-Cuzick—supports risk assessment, which has become best practice in breast screening. This approach helps identify patients who can benefit from personalized screening and helps breast imaging centers drive downstream revenue—such as breast MRI and genetic counseling/testing services. Although there are various models available, the Tyrer-Cuzick v8.0 (IBIS) is […]

Genetic Testing for Breast Cancer: How to Best Incorporate it into Your Imaging Workflow

dna strand

Understanding a patient’s genetics plays an integral role in being able to assess their comprehensive risk for breast cancer. That’s why MagView has incorporated genetic risk factors into its breast cancer risk assessment software and created an easy way for breast centers to integrate genetic testing into their organization’s workflow. The Role of Genetics in […]

Request a Demo